Figure 3
From: The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
![Figure 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13048-015-0143-5/MediaObjects/13048_2015_143_Fig3_HTML.gif)
Validation of DAPK3 as a target of miRNA-1307. Luciferase reporter assay using pMIR-REPORT-DAPK3, pMIR-REPORT-DAPK3-mut and control were shown.